chlorpromazine has been researched along with tetraethylammonium in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bednarczyk, D; Ekins, S; Wikel, JH; Wright, SH | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Horiuchi, K; Horiuchi, KY; Ohnishi, ST | 1 |
| GERTNER, M; JUHASZ, B; MESTER, Z; SZEGEDI, B | 1 |
| KANIAK, J; KASPRZAKOWA, J; KNAPIK, Z | 1 |
| ADES, J; FARJALLAH, A; GIRAUD-COSTA, E; SEFERIAN, V | 1 |
| LAPITSKII, VD | 1 |
8 other study(ies) available for chlorpromazine and tetraethylammonium
| Article | Year |
|---|---|
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.
Topics: Computational Biology; HeLa Cells; Humans; Models, Molecular; Organic Cation Transporter 1; Pyridinium Compounds; Quinolinium Compounds; Structure-Activity Relationship; Transfection | 2003 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
The mechanism of in vitro formation of irreversibly sickled cells and modes of action of its inhibitors.
Topics: Adenosine Triphosphate; Adult; Anemia, Sickle Cell; Calcium; Cell Separation; Chlorpromazine; Erythrocytes; Humans; Oxygen; Partial Pressure; Potassium; Sodium; Tetraethylammonium; Tetraethylammonium Compounds | 1986 |
[Effects of some ganglionic blocking agents and substances with nervous system effect on the biliary tract].
Topics: Biliary Tract; Chlorpromazine; Curare; Ganglionic Blockers; Hexamethonium Compounds; Humans; Magnesium Sulfate; Nervous System; Tetraethylammonium | 1957 |
[Treatment of peripheral vascular diseases with drugs acting on the nervous system].
Topics: Chlorpromazine; Humans; Nervous System; Peripheral Vascular Diseases; Reserpine; Tetraethylammonium; Vascular Diseases | 1958 |
[Action of ganglion-blocking agents on hypothermia induced by chlorpromazine].
Topics: Autonomic Agents; Body Temperature; Chlorpromazine; Hypothermia; Tetraethylammonium | 1954 |
[Features of the action, in relation to age, of aminazine, hexonium and tetamon].
Topics: Aging; Chlorpromazine; Hexamethonium; Hexamethonium Compounds; Tetraethylammonium | 1962 |